Clinical Trials
All Clinical Trials - Page 10 of 75
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT07171723EARLY_Phase 1Completed
Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment
Semaglutide
- NCT07262957Phase 4Recruiting
Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)
Octreotide
- NCT07139548Phase 3Not Yet Recruiting
A Study of RAY1225 Versus Semaglutide as Add-on Therapy to Oral Antidiabetic Drugs in Participants With Type 2 Diabetes
Semaglutide
- NCT07616401N/ARecruiting
MicroRNA and Markers and Therapeutic Response to Romosozumab and Abaloparatide in Postmenopausal Osteoporosis
Abaloparatide
- NCT07165886Phase 2/Phase 3Recruiting
Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors
Octreotide
- NCT06922318Phase 2Recruiting
The COSMYC Trial (COmbined Suppression of MYC)
Gonadorelin
- NCT07091500N/ARecruiting
Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity
Semaglutide
- NCT07121153Phase 1Completed
A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants When Injected Under the Skin.
Amycretin
- NCT07115069N/AActive Not Recruiting
Comparison of Body Composition Changes With Weight Loss Interventions
Tirzepatide
- NCT07081178N/ATerminated
A Non-interventional Study Investigating Semaglutide in Combination With Lifestyle-based Modifications for the Management of Obesity in Real-World Clinical Practice in Germany (WeGo Real Germany).
Semaglutide
- NCT06885736N/ARecruiting
LEAN Mass Preservation With Resistance Exercise and Protein During Semaglutide/Tirzepatide Therapy
Tirzepatide
- NCT06691243Phase 2Active Not Recruiting
Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV
Semaglutide
- NCT07160257Phase 1Active Not Recruiting
A Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes Mellitus
Maridebart-Cafraglutide
- NCT07319286Phase 1/Phase 2Enrolling By Invitation
Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes Mellitus
Dulaglutide
- NCT07065383N/ARecruiting
Rebalancing the Fat Content of the Heart and Muscles
Semaglutide
- NCT07696351Phase 4Recruiting
Ultra-Long GnRH-a Pretreatment for FET Outcomes in Patients With Deep Infiltrating Endometriosis
Gonadorelin
- NCT07096908Phase 4Recruiting
Tirzepatide Use in People With Obesity and Type 1 Diabetes
Tirzepatide
- NCT06903923Phase 2Recruiting
Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy
Semaglutide
- NCT07073417Phase 2Active Not Recruiting
A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)
Semaglutide
- NCT07071974Phase 1Completed
A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body
Survodutide
- NCT07037433Phase 3Recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Maridebart-Cafraglutide
- NCT07097259Phase 1Completed
A Study to Assess the Bioequivalence of Follitropin Alfa Solution in Pen and Follitropin Alfa Powder in Vial in Healthy Downregulated Male Participants
Gonadorelin
- NCT07804719N/AActive Not Recruiting
Possible Sarcopenia, Sarcopenia, and Functional Status in Patients With Primary Sjögren's Syndrome
Follistatin
- NCT06867835Phase 4Completed
Single Dose of Vyleesi in Lactating Female Subjects to Measure the Concentration of Bremelanotide in Breast Milk
PT-141
- NCT06554717Phase 2Recruiting
Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV
Tesamorelin
- NCT07117240Phase 4Enrolling By Invitation
Evaluation of the Efficacy and Safety of GLP-1 Receptor Agonist Therapy In Steroid-Induced Diabetes
Lixisenatide
- NCT06953882Phase 2Recruiting
Impact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine Therapy
Gonadorelin
- NCT06861439Phase 4Active Not Recruiting
GLP-1s to Enhance Lasting Optimal Weight
Tirzepatide
- NCT07064486Phase 3Active Not Recruiting
A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia
Semaglutide
- NCT06759701EARLY_Phase 1Recruiting
Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study
Tirzepatide
- NCT07041983N/AEnrolling By Invitation
24-h Energy Expenditure and Anti-obesity Medication
Tirzepatide
- NCT07042672N/ARecruiting
Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity
Tirzepatide
- NCT07087795Phase 1Active Not Recruiting
A Study to See the Effect of NNC0194-0499 Alone or in Combination With Semaglutide on Blood Sugar Control in People Living With Type 1 Diabetes
Semaglutide
- NCT07012837Phase 3Not Yet Recruiting
Transfusion Reduction in High-Bleeding-Risk Cardiac Surgery With Desmopressin
Desmopressin
- NCT06934642EARLY_Phase 1Recruiting
Effect of Tirzepatide on Markers of MASLD in Patients With Obesity
Tirzepatide
- NCT06937086Phase 3Recruiting
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Tirzepatide
- NCT06937099Phase 3Recruiting
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Tirzepatide
- NCT06973304Phase 3Active Not Recruiting
A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome
Teduglutide
- NCT07037459Phase 3Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Maridebart-Cafraglutide
- NCT07101939Phase 2Recruiting
A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2)
Semaglutide
- NCT06924697N/AEnrolling By Invitation
Effect of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Stimulation on Smoking Consumption in Type 2 Diabetes Patients
Semaglutide
- NCT07239570Phase 4Recruiting
A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease
Semaglutide
- NCT06937749Phase 2Active Not Recruiting
A Study of IBI362 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Mazdutide
- NCT07000955Phase 1/Phase 2Active Not Recruiting
Tolerance and Pharmacokinetic/Pharmacokinetic Study of IBI362 15mg in Patients With Moderate to Severe Obesity
Tirzepatide
- NCT07225829Phase 2Completed
A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and Osteoarthritis
Liraglutide
- NCT06987695Phase 3Active Not Recruiting
Efficacy and Safety of Maridebart Cafraglutide in Adult Participants in Japan Who Have Obesity Disease
Maridebart-Cafraglutide
- NCT06967389N/ARecruiting
Mitigation of Cardiovascular Disease Risks in Children With Extreme Obesity
Semaglutide
- NCT07010432Phase 1Recruiting
The Role of the Amylin Analogue Cagrilintide in Bone Metabolism
Semaglutide
- NCT06931028Phase 3Recruiting
A Study of IBI362 in Chinese Subjects With Obstructive Sleep Apnea and BMI≥28 kg/m2
Mazdutide
- NCT06878664Phase 3Recruiting
Randomized Interval Assessment Trial of Lu177-Dotatate in Slowly Progressive G1-2 Advanced Midgut Neuroendocrine Tumors
Octreotide